Loading

Challenges faced with conventional fed-batch process; EnzeneX™ : The solution and future of biologics manufacturing

June 05, 2024
BioProcess Theater Session
Continuous manufacturing outperforms fed-batch processes by offering uninterrupted processing from cell culture to the final drug substance. It maximizes resource efficiency, achieving a remarkable 10-fold increase in upstream productivity and a 25-50% improvement in downstream, while eliminating multiple hold steps and transfers of in process material. This approach enhances product quality through degradation minimization, enables reduction in emissions, and provides flexible design options for cost-effective manufacturing. Costs per gram can be slashed by up to 40%, making it a highly attractive option for biologics production.
Speakers
Himanshu Gadgil
CEO
Enzene Inc., USA
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS